Search Results

There are 26501 results for: content related to: Morbilliform drug eruption due to pegylated α-interferon can show complete regression after switching to non-pegylated interferon

  1. Drug Reactions

    Rook's Textbook of Dermatology, Seventh Edition

    Tony Burns, Stephen Breathnach, Neil Cox, Christopher Griffiths, Pages: 3765–3944, 2008

    Published Online : 4 FEB 2008, DOI: 10.1002/9780470750520.ch73

  2. Managing generalized interferon-induced eruptions and the effectiveness of desensitization

    Clinical & Experimental Allergy

    Volume 44, Issue 5, May 2014, Pages: 756–764, C. Poreaux, J.-P. Bronowicki, M. Debouverie, J.-L. Schmutz, J. Waton and A. Barbaud

    Version of Record online : 16 APR 2014, DOI: 10.1111/cea.12217

  3. Allergic sensitization to pegylated interferon-α results in drug eruptions

    Allergy

    Volume 70, Issue 7, July 2015, Pages: 775–783, S. Meller, P. A. Gerber, A. Kislat, P. Hevezi, T. Göbel, U. Wiesner, S. Kellermann, E. Bünemann, A. Zlotnik, D. Häussinger, A. Erhardt and B. Homey

    Version of Record online : 6 MAY 2015, DOI: 10.1111/all.12618

  4. You have free access to this content
    JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2014 Update for Genotype 1

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 59–70, Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12272

  5. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  6. Hepatitis C

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt033

  7. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  8. You have free access to this content
    Guidelines for the Management of Hepatitis C Virus Infection

    Hepatology Research

    Volume 43, Issue 1, January 2013, Pages: 1–34, Editors of the Drafting Committee for Hepatitis Management Guidelines: The Japan Society of Hepatology

    Version of Record online : 18 JAN 2013, DOI: 10.1111/hepr.12020

  9. You have free access to this content
    Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection

    Hepatology

    Volume 52, Issue 3, September 2010, Pages: 822–832, Andrew J. Muir, Mitchell L. Shiffman, Atif Zaman, Boris Yoffe, Andrew de la Torre, Steven Flamm, Stuart C. Gordon, Paul Marotta, John M. Vierling, Juan Carlos Lopez-Talavera, Kelly Byrnes-Blake, David Fontana, Jeremy Freeman, Todd Gray, Diana Hausman, Naomi N. Hunder and Eric Lawitz

    Version of Record online : 14 MAY 2010, DOI: 10.1002/hep.23743

  10. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  11. You have free access to this content
    Pharmacodynamics of PEG-IFN α differentiate HIV/HCV coinfected sustained virological responders from nonresponders

    Hepatology

    Volume 43, Issue 5, May 2006, Pages: 943–953, Andrew H. Talal, Ruy M. Ribeiro, Kimberly A. Powers, Michael Grace, Constance Cullen, Musaddeq Hussain, Marianthi Markatou and Alan S. Perelson

    Version of Record online : 20 APR 2006, DOI: 10.1002/hep.21136

  12. Serum interferon-gamma-inducible protein-10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C

    Hepatology Research

    Volume 44, Issue 12, November 2014, Pages: 1208–1216, Kentaro Matsuura, Tsunamasa Watanabe, Sayuki Iijima, Shuko Murakami, Kei Fujiwara, Etsuro Orito, Etsuko Iio, Mio Endo, Atsunori Kusakabe, Noboru Shinkai, Tomokatsu Miyaki, Shunsuke Nojiri, Takashi Joh and Yasuhito Tanaka

    Version of Record online : 17 FEB 2014, DOI: 10.1111/hepr.12294

  13. HBV DNA suppression in HBeAg-positive chronic hepatitis B patients treated with peginterferon or placebo

    Journal of Medical Virology

    Volume 83, Issue 11, November 2011, Pages: 1917–1923, Bettina E. Hansen, Vincent Rijckborst, Martijn J. ter Borg and Prof. Harry L.A. Janssen

    Version of Record online : 13 SEP 2011, DOI: 10.1002/jmv.22208

  14. You have free access to this content
    Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: A randomized controlled trial

    Hepatology

    Volume 50, Issue 4, October 2009, Pages: 1045–1055, Stuart K. Roberts, Martin D. Weltman, Darrell H. G. Crawford, Geoffrey W. McCaughan, William Sievert, Wendy S. Cheng, William Rawlinson, Paul V. Desmond, Phillipa S. Marks, Motoko Yoshihara, Bishoy Rizkalla, Jean K. DePamphilis, Gregory J. Dore and Chariot Study Group

    Version of Record online : 15 JUN 2009, DOI: 10.1002/hep.23130

  15. Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: Results from Kyushu University Liver Disease Study

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 7, July 2012, Pages: 1233–1240, Eiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara, Kazuhiro Takahashi, Hideyuki Nomura, Yuichi Tanabe, Takeaki Satoh, Toshihiro Maruyama, Makoto Nakamuta, Kazuhiro Kotoh, Koichi Azuma, Kazufumi Dohmen, Shinji Shimoda, Jun Hayashi and The Kyushu University Liver Disease Study [KULDS] Group

    Version of Record online : 19 JUN 2012, DOI: 10.1111/j.1440-1746.2011.06965.x

  16. You have free access to this content
    Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results

    Hepatology

    Volume 49, Issue 6, June 2009, Pages: 1838–1846, Bruce R. Bacon, Mitchell L. Shiffman, Flavia Mendes, Reem Ghalib, Tarek Hassanein, Giuseppe Morelli, Shobha Joshi, Kenneth Rothstein, Paul Kwo and Norman Gitlin

    Version of Record online : 2 FEB 2009, DOI: 10.1002/hep.22871

  17. You have free access to this content
    Why do I treat HBeAg-negative chronic hepatitis B patients with pegylated interferon?

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 157–163, Pietro Lampertico, Mauro Viganò and Massimo Colombo

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12064

  18. You have free access to this content
    A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative

    Hepatology

    Volume 42, Issue 1, July 2005, Pages: 77–85, Vassiliki-Anastasia Sypsa, Konstantinos Mimidis, Nicholas C. Tassopoulos, Dimitrios Chrysagis, Themistoklis Vassiliadis, Antonios Moulakakis, Maria Raptopoulou, Caterina Haida and Angelos Hatzakis

    Version of Record online : 16 JUN 2005, DOI: 10.1002/hep.20738

  19. Efficacy of pegylated interferon-α2a monotherapy in Japanese children with chronic hepatitis C

    Hepatology Research

    Volume 41, Issue 5, May 2011, Pages: 399–404, Tomoyuki Tsunoda, Ayano Inui, Yuri Etani, Yuki Kiyohara, Tokio Sugiura, Koichi Ito, Reiko Miyazawa, Ikuo Nagata, Shinobu Ida, Tomoo Fujisawa and Working Group for the Study of Pegylated Monotherapy for Children with Chronic Hepatitis C in the Japan Society of Pediatric Hepatology

    Version of Record online : 26 APR 2011, DOI: 10.1111/j.1872-034X.2011.00789.x

  20. You have free access to this content
    The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naïve hepatitis C patients

    Hepatology

    Volume 49, Issue 5, May 2009, Pages: 1460–1468, Robert Flisiak, Saya V. Feinman, Maciej Jablkowski, Andrzej Horban, Wieslaw Kryczka, Małgorzata Pawlowska, Jenny E. Heathcote, Giuseppe Mazzella, Carmen Vandelli, Valérie Nicolas-Métral, Pierre Grosgurin, Jorge S. Liz, Pietro Scalfaro, Hervé Porchet and Raf Crabbé

    Version of Record online : 4 FEB 2009, DOI: 10.1002/hep.22835